Logo image of AHG

AKSO HEALTH GROUP (AHG) Stock Fundamental Analysis

NASDAQ:AHG - Nasdaq - US98422P1084 - ADR

1.49  -0.05 (-3.25%)

Fundamental Rating

3

AHG gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 108 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for AHG as it has an excellent financial health rating, but there are worries on the profitability. AHG has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year AHG has reported negative net income.
In the past year AHG had a positive cash flow from operations.
In the past 5 years AHG always reported negative net income.
In multiple years AHG reported negative operating cash flow during the last 5 years.
AHG Yearly Net Income VS EBIT VS OCF VS FCFAHG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

The Return On Assets of AHG (-6.66%) is worse than 66.36% of its industry peers.
AHG has a Return On Equity (-6.84%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -6.66%
ROE -6.84%
ROIC N/A
ROA(3y)-13.47%
ROA(5y)-47.73%
ROE(3y)-53.44%
ROE(5y)-101.9%
ROIC(3y)N/A
ROIC(5y)N/A
AHG Yearly ROA, ROE, ROICAHG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

Looking at the Gross Margin, with a value of 5.06%, AHG is doing worse than 80.37% of the companies in the same industry.
AHG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AHG Yearly Profit, Operating, Gross MarginsAHG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

8

2. Health

2.1 Basic Checks

The debt/assets ratio for AHG has been reduced compared to a year ago.
AHG Yearly Shares OutstandingAHG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
AHG Yearly Total Debt VS Total AssetsAHG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

AHG has an Altman-Z score of 98.02. This indicates that AHG is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 98.02, AHG belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
AHG has a debt to FCF ratio of 1.48. This is a very positive value and a sign of high solvency as it would only need 1.48 years to pay back of all of its debts.
The Debt to FCF ratio of AHG (1.48) is better than 87.85% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that AHG is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.01, AHG belongs to the best of the industry, outperforming 82.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 1.48
Altman-Z 98.02
ROIC/WACCN/A
WACCN/A
AHG Yearly LT Debt VS Equity VS FCFAHG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

AHG has a Current Ratio of 39.52. This indicates that AHG is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of AHG (39.52) is better than 100.00% of its industry peers.
A Quick Ratio of 39.46 indicates that AHG has no problem at all paying its short term obligations.
The Quick ratio of AHG (39.46) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 39.52
Quick Ratio 39.46
AHG Yearly Current Assets VS Current LiabilitesAHG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

AHG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -220.05%.
The Revenue for AHG has decreased by -81.71% in the past year. This is quite bad
Measured over the past years, AHG shows a decrease in Revenue. The Revenue has been decreasing by -8.18% on average per year.
EPS 1Y (TTM)-220.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.8%
Revenue 1Y (TTM)-81.71%
Revenue growth 3YN/A
Revenue growth 5Y-8.18%
Sales Q2Q%16.16%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AHG Yearly Revenue VS EstimatesAHG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AHG Yearly EPS VS EstimatesAHG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AHG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AHG Price Earnings VS Forward Price EarningsAHG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as AHG.
Industry RankSector Rank
P/FCF 439.78
EV/EBITDA N/A
AHG Per share dataAHG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AHG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AKSO HEALTH GROUP

NASDAQ:AHG (1/21/2025, 8:00:00 PM)

1.49

-0.05 (-3.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)12-04 2023-12-04
Earnings (Next)N/A N/A
Inst Owners0.1%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap594.24M
AnalystsN/A
Price TargetN/A
Short Float %0.14%
Short Ratio0.81
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.6
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 246.13
P/FCF 439.78
P/OCF 439.78
P/B 4.29
P/tB 4.29
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY0.23%
OCF(TTM)0
OCFY0.23%
SpS0.01
BVpS0.35
TBVpS0.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.66%
ROE -6.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.06%
FCFM 55.97%
ROA(3y)-13.47%
ROA(5y)-47.73%
ROE(3y)-53.44%
ROE(5y)-101.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 1.48
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 39.52
Quick Ratio 39.46
Altman-Z 98.02
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-220.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.8%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-81.71%
Revenue growth 3YN/A
Revenue growth 5Y-8.18%
Sales Q2Q%16.16%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y141.58%
FCF growth 3Y-48.79%
FCF growth 5YN/A
OCF growth 1Y141.58%
OCF growth 3Y-48.79%
OCF growth 5YN/A